Denosumab Timing — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Administer denosumab on time
Denosumab must be administered strictly every 6 months without delay. Missing or delaying doses leads to rapid rebound bone loss with significantly increased vertebral fracture risk within months of the missed dose. The new vertebral fracture occurred while ON denosumab, suggesting severe osteoporosis requiring therapy intensification (consider adding teriparatide sequentially) but the immediate priority is to NOT miss the scheduled dose. Investigation for secondary causes (myeloma, metastases) is also appropriate.
Reference: eTG – 2025 – Rheumatology; ASBMR – 2022 – Denosumab Position Statement